According to Latest Study, the global market for Antiemetics for Cancer Treatment should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Antiemetics for Cancer Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Antiemetics for Cancer Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

By segment, Highly Emetogenic Chemotherapy grew percent to account for percent of the total market sales, and Moderately Emetogenic Chemotherapy grew percent.

Emetogenic symptoms are associated with nausea and vomiting associated with cancer treatments such as chemotherapy, radiation therapy, and drug therapy. Nausea and vomiting are major side effects of cancer treatment. It is important that nausea and vomiting are controlled so patients can continue treatment and have a better quality of life. Nausea and vomiting, primarily due to, can also be induced in patients receiving chemotherapy and radiation therapy of the brain, gastrointestinal tract, or liver.

This report studies and analyses global Antiemetics for Cancer Treatment status and future trends, helps the client to determine the Antiemetics for Cancer Treatment market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Antiemetics for Cancer Treatment, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights

(1) Global Antiemetics for Cancer Treatment market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)

(2) Global Antiemetics for Cancer Treatment sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)

(3) China Antiemetics for Cancer Treatment sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)

(4) Global Antiemetics for Cancer Treatment key consuming regions, consumption quantity, consumption value and demand structure

(5) Global Antiemetics for Cancer Treatment key producing regions, capacity, production, and year over year growth

(6) Antiemetics for Cancer Treatment industry chains, upstream, midstream and downstream

Market segment by players, this report covers

Heron Therapeutics, Inc

Sandoz International GmbH

Merck & Co., Inc

Eisai Co., Ltd

Teva Pharmaceutical Industries Ltd

F. Hoffmann-La Roche Ltd

Mylan N.V

GSK plc

Mundipharma International

Baxter

Bayer AG

Cipla Inc

Sanofi

Sun Pharmaceutical Industries Ltd

Qilu Pharmaceutical Co.,Ltd

Market segment by Type, covers

Serotonin Receptor Antagonists

Neurokinin-1 Receptor Antagonist

Corticosteroids

Olanzapine

Other

Market segment by Application, can be divided into

Highly Emetogenic Chemotherapy

Moderately Emetogenic Chemotherapy

Low Emetogenic Chemotherapy

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Report Includes:

Chapter 1: to describe Antiemetics for Cancer Treatment product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.

Chapter 2: Global Antiemetics for Cancer Treatment market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023

Chapter 3: China Antiemetics for Cancer Treatment market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023

Chapter 4: Global key producing regions of Antiemetics for Cancer Treatment, percent & CAGR, 2018-2029

Chapter 5: Antiemetics for Cancer Treatment industry chain, upstream, medium-stream, and downstream.

Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.

Chapter 11: Conclusions

1 Market Overview

1.1 Antiemetics for Cancer Treatment Definition

1.2 Global Antiemetics for Cancer Treatment Market Size and Forecast

1.2.1 By Consumption Value, Global Antiemetics for Cancer Treatment Market Size，2018-2029

1.2.2 By Sales Quantity, Global Antiemetics for Cancer Treatment Market Size，2018-2029

1.2.3 Global Antiemetics for Cancer Treatment Average Selling Price (ASP)，2018-2029

1.3 China Antiemetics for Cancer Treatment Market Size and Forecast

1.3.1 By Consumption Value, China Antiemetics for Cancer Treatment Market Size，2018-2029

1.3.2 By Sales Quantity, China Antiemetics for Cancer Treatment Market Size，2018-2029

1.3.3 China Antiemetics for Cancer Treatment Average Selling Price (ASP)， 2018-2029

1.4 Share of China Antiemetics for Cancer Treatment Market with Respect to the Global Market

1.4.1 By Consumption Value, China Antiemetics for Cancer Treatment Market Share in Global, 2018-2029

1.4.2 By Sales Quantity, China Antiemetics for Cancer Treatment Market Share in Global, 2018-2029

1.4.3 Antiemetics for Cancer Treatment Market Size: China VS Global, 2018-2029

1.5 Antiemetics for Cancer Treatment Market Dynamics

1.5.1 Antiemetics for Cancer Treatment Market Drivers

1.5.2 Antiemetics for Cancer Treatment Market Restraints

1.5.3 Antiemetics for Cancer Treatment Industry Trends

1.5.4 Antiemetics for Cancer Treatment Industry Policy

2 Global Leading Manufacturers and Market Share

2.1 By Revenue of Antiemetics for Cancer Treatment, Global Market Share by Company, 2018-2023

2.2 By Sales Quantity of Antiemetics for Cancer Treatment, Global Market Share by Company, 2018-2023

2.3 Antiemetics for Cancer Treatment Average Selling Price (ASP) by Company, 2018-2023

2.4 Global Antiemetics for Cancer Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)

2.5 Global Antiemetics for Cancer Treatment Concentration Ratio

2.6 Global Antiemetics for Cancer Treatment Mergers & Acquisitions, Expansion Plans

2.7 Global Antiemetics for Cancer Treatment Manufacturers Product Type

2.8 Head Office and Antiemetics for Cancer Treatment Production Site of Key Manufacturer

2.9 Antiemetics for Cancer Treatment Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share

3.1 By Revenue of Antiemetics for Cancer Treatment, China Market Share by Company, 2018-2023

3.2 By Sales Quantity of Antiemetics for Cancer Treatment, China Market Share by Company, 2018-2023

3.3 China Antiemetics for Cancer Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions

4.1 Global Antiemetics for Cancer Treatment Capacity, Output and Capacity Utilization, 2018-2029

4.2 Global Antiemetics for Cancer Treatment Capacity by Region

4.3 Global Antiemetics for Cancer Treatment Production & Forecast by Region, 2018 VS 2022 VS 2029

4.4 Global Antiemetics for Cancer Treatment Production by Region, 2018-2029

4.5 Global Antiemetics for Cancer Treatment Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 Antiemetics for Cancer Treatment Industry Chain

5.2 Antiemetics for Cancer Treatment Upstream Analysis

5.2.1 Antiemetics for Cancer Treatment Core Raw Materials

5.2.2 Main Manufacturers of Antiemetics for Cancer Treatment Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Antiemetics for Cancer Treatment Production Mode

5.6 Antiemetics for Cancer Treatment Procurement Model

5.7 Antiemetics for Cancer Treatment Industry Sales Model and Sales Channels

5.7.1 Antiemetics for Cancer Treatment Sales Model

5.7.2 Antiemetics for Cancer Treatment Typical Distributors

6 Sights by Type

6.1 Antiemetics for Cancer Treatment Classification

6.1.1 Serotonin Receptor Antagonists

6.1.2 Neurokinin-1 Receptor Antagonist

6.1.3 Corticosteroids

6.1.4 Olanzapine

6.1.5 Other

6.2 By Type, Global Antiemetics for Cancer Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global Antiemetics for Cancer Treatment Consumption Value, 2018-2029

6.4 By Type, Global Antiemetics for Cancer Treatment Sales Quantity, 2018-2029

6.5 By Type, Global Antiemetics for Cancer Treatment Average Selling Price (ASP), 2018-2029

7 Sights by Application

7.1 Antiemetics for Cancer Treatment Segment by Application

7.1.1 Highly Emetogenic Chemotherapy

7.1.2 Moderately Emetogenic Chemotherapy

7.1.3 Low Emetogenic Chemotherapy

7.2 By Application, Global Antiemetics for Cancer Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global Antiemetics for Cancer Treatment Consumption Value, 2018-2029

7.4 By Application, Global Antiemetics for Cancer Treatment Sales Quantity, 2018-2029

7.5 By Application, Global Antiemetics for Cancer Treatment Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global Antiemetics for Cancer Treatment Consumption Value, 2018 VS 2022 VS 2029

8.2 By Region, Global Antiemetics for Cancer Treatment Consumption Value, 2018-2029

8.3 By Region, Global Antiemetics for Cancer Treatment Sales Quantity, 2018-2029

8.4 North America

8.4.1 North America Antiemetics for Cancer Treatment & Forecasts, 2018-2029

8.4.2 By Country, North America Antiemetics for Cancer Treatment Market Size Market Share

8.5 Europe

8.5.1 Europe Antiemetics for Cancer Treatment Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe Antiemetics for Cancer Treatment Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Antiemetics for Cancer Treatment Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific Antiemetics for Cancer Treatment Market Size Market Share

8.7 South America

8.7.1 South America Antiemetics for Cancer Treatment Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America Antiemetics for Cancer Treatment Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Antiemetics for Cancer Treatment Market Size & CAGR, 2018 VS 2022 VS 2029

9.2 By Country, Global Antiemetics for Cancer Treatment Consumption Value, 2018-2029

9.3 By Country, Global Antiemetics for Cancer Treatment Sales Quantity, 2018-2029

9.4 U.S.

9.4.1 U.S. Antiemetics for Cancer Treatment Market Size, 2018-2029

9.4.2 By Type, U.S. Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029

9.4.3 By Application, U.S. Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Antiemetics for Cancer Treatment Market Size, 2018-2029

9.5.2 By Type, Europe Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029

9.5.3 By Application, Europe Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029

9.6 China

9.6.1 China Antiemetics for Cancer Treatment Market Size, 2018-2029

9.6.2 By Type, China Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029

9.6.3 By Application, China Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Antiemetics for Cancer Treatment Market Size, 2018-2029

9.7.2 By Type, Japan Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029

9.7.3 By Application, Japan Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Antiemetics for Cancer Treatment Market Size, 2018-2029

9.8.2 By Type, South Korea Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029

9.8.3 By Application, South Korea Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Antiemetics for Cancer Treatment Market Size, 2018-2029

9.9.2 By Type, Southeast Asia Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029

9.9.3 By Application, Southeast Asia Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029

9.10 India

9.10.1 India Antiemetics for Cancer Treatment Market Size, 2018-2029

9.10.2 By Type, India Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029

9.10.3 By Application, India Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029

9.11 Middle East & Africa

9.11.1 Middle East & Africa Antiemetics for Cancer Treatment Market Size, 2018-2029

9.11.2 By Type, Middle East & Africa Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029

9.11.3 By Application, Middle East & Africa Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Heron Therapeutics, Inc

10.1.1 Heron Therapeutics, Inc Company Information, Head Office, Market Area, and Industry Position

10.1.2 Heron Therapeutics, Inc Antiemetics for Cancer Treatment Models, Specifications, and Application

10.1.3 Heron Therapeutics, Inc Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.1.4 Heron Therapeutics, Inc Company Profile and Main Business

10.1.5 Heron Therapeutics, Inc Recent Developments

10.2 Sandoz International GmbH

10.2.1 Sandoz International GmbH Company Information, Head Office, Market Area, and Industry Position

10.2.2 Sandoz International GmbH Antiemetics for Cancer Treatment Models, Specifications, and Application

10.2.3 Sandoz International GmbH Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.2.4 Sandoz International GmbH Company Profile and Main Business

10.2.5 Sandoz International GmbH Recent Developments

10.3 Merck & Co., Inc

10.3.1 Merck & Co., Inc Company Information, Head Office, Market Area, and Industry Position

10.3.2 Merck & Co., Inc Antiemetics for Cancer Treatment Models, Specifications, and Application

10.3.3 Merck & Co., Inc Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.3.4 Merck & Co., Inc Company Profile and Main Business

10.3.5 Merck & Co., Inc Recent Developments

10.4 Eisai Co., Ltd

10.4.1 Eisai Co., Ltd Company Information, Head Office, Market Area, and Industry Position

10.4.2 Eisai Co., Ltd Antiemetics for Cancer Treatment Models, Specifications, and Application

10.4.3 Eisai Co., Ltd Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.4.4 Eisai Co., Ltd Company Profile and Main Business

10.4.5 Eisai Co., Ltd Recent Developments

10.5 Teva Pharmaceutical Industries Ltd

10.5.1 Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area, and Industry Position

10.5.2 Teva Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Models, Specifications, and Application

10.5.3 Teva Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.5.4 Teva Pharmaceutical Industries Ltd Company Profile and Main Business

10.5.5 Teva Pharmaceutical Industries Ltd Recent Developments

10.6 F. Hoffmann-La Roche Ltd

10.6.1 F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area, and Industry Position

10.6.2 F. Hoffmann-La Roche Ltd Antiemetics for Cancer Treatment Models, Specifications, and Application

10.6.3 F. Hoffmann-La Roche Ltd Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.6.4 F. Hoffmann-La Roche Ltd Company Profile and Main Business

10.6.5 F. Hoffmann-La Roche Ltd Recent Developments

10.7 Mylan N.V

10.7.1 Mylan N.V Company Information, Head Office, Market Area, and Industry Position

10.7.2 Mylan N.V Antiemetics for Cancer Treatment Models, Specifications, and Application

10.7.3 Mylan N.V Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.7.4 Mylan N.V Company Profile and Main Business

10.7.5 Mylan N.V Recent Developments

10.8 GSK plc

10.8.1 GSK plc Company Information, Head Office, Market Area, and Industry Position

10.8.2 GSK plc Antiemetics for Cancer Treatment Models, Specifications, and Application

10.8.3 GSK plc Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.8.4 GSK plc Company Profile and Main Business

10.8.5 GSK plc Recent Developments

10.9 Mundipharma International

10.9.1 Mundipharma International Company Information, Head Office, Market Area, and Industry Position

10.9.2 Mundipharma International Antiemetics for Cancer Treatment Models, Specifications, and Application

10.9.3 Mundipharma International Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.9.4 Mundipharma International Company Profile and Main Business

10.9.5 Mundipharma International Recent Developments

10.10 Baxter

10.10.1 Baxter Company Information, Head Office, Market Area, and Industry Position

10.10.2 Baxter Antiemetics for Cancer Treatment Models, Specifications, and Application

10.10.3 Baxter Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.10.4 Baxter Company Profile and Main Business

10.10.5 Baxter Recent Developments

10.11 Bayer AG

10.11.1 Bayer AG Company Information, Head Office, Market Area, and Industry Position

10.11.2 Bayer AG Antiemetics for Cancer Treatment Models, Specifications, and Application

10.11.3 Bayer AG Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.11.4 Bayer AG Company Profile and Main Business

10.11.5 Bayer AG Recent Developments

10.12 Cipla Inc

10.12.1 Cipla Inc Company Information, Head Office, Market Area, and Industry Position

10.12.2 Cipla Inc Antiemetics for Cancer Treatment Models, Specifications, and Application

10.12.3 Cipla Inc Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.12.4 Cipla Inc Company Profile and Main Business

10.12.5 Cipla Inc Recent Developments

10.13 Sanofi

10.13.1 Sanofi Company Information, Head Office, Market Area, and Industry Position

10.13.2 Sanofi Antiemetics for Cancer Treatment Models, Specifications, and Application

10.13.3 Sanofi Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.13.4 Sanofi Company Profile and Main Business

10.13.5 Sanofi Recent Developments

10.14 Sun Pharmaceutical Industries Ltd

10.14.1 Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area, and Industry Position

10.14.2 Sun Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Models, Specifications, and Application

10.14.3 Sun Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.14.4 Sun Pharmaceutical Industries Ltd Company Profile and Main Business

10.14.5 Sun Pharmaceutical Industries Ltd Recent Developments

10.15 Qilu Pharmaceutical Co.,Ltd

10.15.1 Qilu Pharmaceutical Co.,Ltd Company Information, Head Office, Market Area, and Industry Position

10.15.2 Qilu Pharmaceutical Co.,Ltd Antiemetics for Cancer Treatment Models, Specifications, and Application

10.15.3 Qilu Pharmaceutical Co.,Ltd Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.15.4 Qilu Pharmaceutical Co.,Ltd Company Profile and Main Business

10.15.5 Qilu Pharmaceutical Co.,Ltd Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Antiemetics for Cancer Treatment Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Antiemetics for Cancer Treatment Market Restraints

Table 3. Antiemetics for Cancer Treatment Market Trends

Table 4. Antiemetics for Cancer Treatment Industry Policy

Table 5. Global Antiemetics for Cancer Treatment Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Antiemetics for Cancer Treatment Revenue Share by Company, 2018-2023, Ranked by Data of 2022

Table 7. Global Antiemetics for Cancer Treatment Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 8. Global Antiemetics for Cancer Treatment Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 9. Global Antiemetics for Cancer Treatment Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)

Table 10. Global Antiemetics for Cancer Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Antiemetics for Cancer Treatment Mergers & Acquisitions, Expansion Plans

Table 12. Global Antiemetics for Cancer Treatment Manufacturers Product Type

Table 13. Head Office and Antiemetics for Cancer Treatment Production Site of Key Manufacturer

Table 14. Antiemetics for Cancer Treatment Capacity of Major Manufacturers and Future Plan

Table 15. China Antiemetics for Cancer Treatment Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 16. China Antiemetics for Cancer Treatment Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 17. China Antiemetics for Cancer Treatment Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 18. Global Antiemetics for Cancer Treatment Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 19. Global Antiemetics for Cancer Treatment Production by Region, 2018-2023, (K Units)

Table 20. Global Antiemetics for Cancer Treatment Production Forecast by Region, 2024-2029, (K Units)

Table 21. Global Key Players of Antiemetics for Cancer Treatment Upstream (Raw Materials)

Table 22. Global Antiemetics for Cancer Treatment Typical Customers

Table 23. Antiemetics for Cancer Treatment Typical Distributors

Table 24. By Type, Global Antiemetics for Cancer Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 25. By Application, Global Antiemetics for Cancer Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 26. By Region, Global Antiemetics for Cancer Treatment Consumption Value, 2018 VS 2022 VS 2029, US$ Million

Table 27. By Region, Global Antiemetics for Cancer Treatment Consumption Value, 2018-2029, US$ Million

Table 28. By Region, Global Antiemetics for Cancer Treatment Sales Quantity, 2018-2029, (K Units)

Table 29. By Country, Global Antiemetics for Cancer Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Country, Global Antiemetics for Cancer Treatment Consumption Value, 2018-2029, US$ Million

Table 31. By Country, Global Antiemetics for Cancer Treatment Consumption Value Market Share, 2018-2029

Table 32. By Country, Global Antiemetics for Cancer Treatment Sales Quantity, 2018-2029, (K Units)

Table 33. By Country, Global Antiemetics for Cancer Treatment Sales Quantity Market Share, 2018-2029

Table 34. Heron Therapeutics, Inc Company Information, Head Office, Market Area, and Industry Position

Table 35. Heron Therapeutics, Inc Antiemetics for Cancer Treatment Models, Specifications, and Application

Table 36. Heron Therapeutics, Inc Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 37. Heron Therapeutics, Inc Company Profile and Main Business

Table 38. Heron Therapeutics, Inc Recent Developments

Table 39. Sandoz International GmbH Company Information, Head Office, Market Area, and Industry Position

Table 40. Sandoz International GmbH Antiemetics for Cancer Treatment Models, Specifications, and Application

Table 41. Sandoz International GmbH Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Sandoz International GmbH Company Profile and Main Business

Table 43. Sandoz International GmbH Recent Developments

Table 44. Merck & Co., Inc Company Information, Head Office, Market Area, and Industry Position

Table 45. Merck & Co., Inc Antiemetics for Cancer Treatment Models, Specifications, and Application

Table 46. Merck & Co., Inc Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Merck & Co., Inc Company Profile and Main Business

Table 48. Merck & Co., Inc Recent Developments

Table 49. Eisai Co., Ltd Company Information, Head Office, Market Area, and Industry Position

Table 50. Eisai Co., Ltd Antiemetics for Cancer Treatment Models, Specifications, and Application

Table 51. Eisai Co., Ltd Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Eisai Co., Ltd Company Profile and Main Business

Table 53. Eisai Co., Ltd Recent Developments

Table 54. Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area, and Industry Position

Table 55. Teva Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Models, Specifications, and Application

Table 56. Teva Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Teva Pharmaceutical Industries Ltd Company Profile and Main Business

Table 58. Teva Pharmaceutical Industries Ltd Recent Developments

Table 59. F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area, and Industry Position

Table 60. F. Hoffmann-La Roche Ltd Antiemetics for Cancer Treatment Models, Specifications, and Application

Table 61. F. Hoffmann-La Roche Ltd Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. F. Hoffmann-La Roche Ltd Company Profile and Main Business

Table 63. F. Hoffmann-La Roche Ltd Recent Developments

Table 64. Mylan N.V Company Information, Head Office, Market Area, and Industry Position

Table 65. Mylan N.V Antiemetics for Cancer Treatment Models, Specifications, and Application

Table 66. Mylan N.V Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Mylan N.V Company Profile and Main Business

Table 68. Mylan N.V Recent Developments

Table 69. GSK plc Company Information, Head Office, Market Area, and Industry Position

Table 70. GSK plc Antiemetics for Cancer Treatment Models, Specifications, and Application

Table 71. GSK plc Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. GSK plc Company Profile and Main Business

Table 73. GSK plc Recent Developments

Table 74. Mundipharma International Company Information, Head Office, Market Area, and Industry Position

Table 75. Mundipharma International Antiemetics for Cancer Treatment Models, Specifications, and Application

Table 76. Mundipharma International Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Mundipharma International Company Profile and Main Business

Table 78. Mundipharma International Recent Developments

Table 79. Baxter Company Information, Head Office, Market Area, and Industry Position

Table 80. Baxter Antiemetics for Cancer Treatment Models, Specifications, and Application

Table 81. Baxter Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Baxter Company Profile and Main Business

Table 83. Baxter Recent Developments

Table 84. Bayer AG Company Information, Head Office, Market Area, and Industry Position

Table 85. Bayer AG Antiemetics for Cancer Treatment Models, Specifications, and Application

Table 86. Bayer AG Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 87. Bayer AG Company Profile and Main Business

Table 88. Bayer AG Recent Developments

Table 89. Cipla Inc Company Information, Head Office, Market Area, and Industry Position

Table 90. Cipla Inc Antiemetics for Cancer Treatment Models, Specifications, and Application

Table 91. Cipla Inc Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 92. Cipla Inc Company Profile and Main Business

Table 93. Cipla Inc Recent Developments

Table 94. Sanofi Company Information, Head Office, Market Area, and Industry Position

Table 95. Sanofi Antiemetics for Cancer Treatment Models, Specifications, and Application

Table 96. Sanofi Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 97. Sanofi Company Profile and Main Business

Table 98. Sanofi Recent Developments

Table 99. Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area, and Industry Position

Table 100. Sun Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Models, Specifications, and Application

Table 101. Sun Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 102. Sun Pharmaceutical Industries Ltd Company Profile and Main Business

Table 103. Sun Pharmaceutical Industries Ltd Recent Developments

Table 104. Qilu Pharmaceutical Co.,Ltd Company Information, Head Office, Market Area, and Industry Position

Table 105. Qilu Pharmaceutical Co.,Ltd Antiemetics for Cancer Treatment Models, Specifications, and Application

Table 106. Qilu Pharmaceutical Co.,Ltd Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 107. Qilu Pharmaceutical Co.,Ltd Company Profile and Main Business

Table 108. Qilu Pharmaceutical Co.,Ltd Recent Developments

List of Figures

Figure 1. Antiemetics for Cancer Treatment Picture

Figure 2. Global Antiemetics for Cancer Treatment Consumption Value, (US$ million) & (2018-2029)

Figure 3. Global Antiemetics for Cancer Treatment Sales Quantity, (K Units) & (2018-2029)

Figure 4. Global Antiemetics for Cancer Treatment Average Selling Price (ASP), (2018-2029) & (US$/Unit)

Figure 5. China Antiemetics for Cancer Treatment Consumption Value, (US$ million) & (2018-2029)

Figure 6. China Antiemetics for Cancer Treatment Sales Quantity (K Units) & (2018-2029)

Figure 7. China Antiemetics for Cancer Treatment Average Selling Price (ASP), (US$/Unit) & (2018-2029)

Figure 8. By Consumption Value, China Antiemetics for Cancer Treatment Market Share of Global, 2018-2029

Figure 9. By Sales Quantity, China Antiemetics for Cancer Treatment Market Share of Global, 2018-2029

Figure 10. Global Antiemetics for Cancer Treatment Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 11. China Antiemetics for Cancer Treatment Key Participants, Market Share, 2022

Figure 12. Global Antiemetics for Cancer Treatment Capacity, Production and Capacity Utilization, 2018-2029

Figure 13. Global Antiemetics for Cancer Treatment Capacity Market Share by Region, 2022 VS 2029

Figure 14. Global Antiemetics for Cancer Treatment Production Market Share & Forecast by Region, 2018-2029

Figure 15. Antiemetics for Cancer Treatment Industry Chain

Figure 16. Antiemetics for Cancer Treatment Procurement Model

Figure 17. Antiemetics for Cancer Treatment Sales Model

Figure 18. Antiemetics for Cancer Treatment Sales Channels, Direct Sales, and Distribution

Figure 19. Serotonin Receptor Antagonists

Figure 20. Neurokinin-1 Receptor Antagonist

Figure 21. Corticosteroids

Figure 22. Olanzapine

Figure 23. Other

Figure 24. By Type, Global Antiemetics for Cancer Treatment Consumption Value, 2018-2029, US$ Million

Figure 25. By Type, Global Antiemetics for Cancer Treatment Consumption Value Market Share, 2018-2029

Figure 26. By Type, Global Antiemetics for Cancer Treatment Sales Quantity, 2018-2029, (K Units)

Figure 27. By Type, Global Antiemetics for Cancer Treatment Sales Quantity Market Share, 2018-2029

Figure 28. By Type, Global Antiemetics for Cancer Treatment Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 29. Highly Emetogenic Chemotherapy

Figure 30. Moderately Emetogenic Chemotherapy

Figure 31. Low Emetogenic Chemotherapy

Figure 32. By Application, Global Antiemetics for Cancer Treatment Consumption Value, 2018-2029, US$ Million

Figure 33. By Application, Global Antiemetics for Cancer Treatment Consumption Value Market Share, 2018-2029

Figure 34. By Application, Global Antiemetics for Cancer Treatment Sales Quantity, 2018-2029, (K Units)

Figure 35. By Application, Global Antiemetics for Cancer Treatment Sales Quantity Market Share, 2018-2029

Figure 36. By Application, Global Antiemetics for Cancer Treatment Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 37. By Region, Global Antiemetics for Cancer Treatment Consumption Value Market Share, 2018-2029

Figure 38. By Region, Global Antiemetics for Cancer Treatment Sales Quantity Market Share, 2018-2029

Figure 39. North America Antiemetics for Cancer Treatment Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 40. By Country, North America Antiemetics for Cancer Treatment Consumption Value Market Share, 2022

Figure 41. Europe Antiemetics for Cancer Treatment Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 42. By Country, Europe Antiemetics for Cancer Treatment Consumption Value Market Share, 2022

Figure 43. Asia Pacific Antiemetics for Cancer Treatment Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 44. By Country/Region, Asia Pacific Antiemetics for Cancer Treatment Consumption Value Market Share, 2022

Figure 45. South America Antiemetics for Cancer Treatment Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 46. By Country, South America Antiemetics for Cancer Treatment Consumption Value Market Share, 2022

Figure 47. Middle East & Africa Antiemetics for Cancer Treatment Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 48. U.S. Antiemetics for Cancer Treatment Sales Quantity, 2018-2029, (K Units)

Figure 49. By Type, U.S. Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 50. By Application, U.S. Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 51. Europe Antiemetics for Cancer Treatment Sales Quantity, 2018-2029, (K Units)

Figure 52. By Type, Europe Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 53. By Application, Europe Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 54. China Antiemetics f